SHL Group has announced it will be exhibiting at the Prefilled Syringe Seminar 2018 in Tokyo.

Held by the Parenteral Drug Association (PDA) Japan Chapter from 22 May to 23 May, the annual seminar will bring together global pharmaceutical and medical device experts in an exploration of this year’s theme: the best solution for the patient from the viewpoint of drugs, containers and devices.

SHL Group will join the event with a showcase of its advanced drug delivery solutions, which include innovative offerings for high-volume/high-viscosity formulations designed to meet the needs of next-generation therapies.

For the first time in Japan, SHL will be demonstrating Maggie®, a high-volume cartridge-based auto-injector built with the market-proven Needle Isolation Technology (NIT®). SHL will also present its high-volume Molly® 2.25, which offers a shorter development timeline for faster commercialisation, and Rotaject®, a state-of-the-art constant force technology that safely delivers viscosities up to several hundred centipoises within seconds.

SHL is pleased to bring its latest portfolio to Japan, a leading market in Asia for self-administered injection devices, and to help biotech and pharma players from around the world to meet their clinical and commercialisation needs.

To find out more about SHL’s auto-injection devices and digital solutions, stop by the Sola City Conference Center in Tokyo, Japan, from 22 May to 23 May.